Skip to main content
Erschienen in: Heart and Vessels 3/2019

29.08.2018 | Original Article

Accumulation of gold nano-rods in the failing heart of transgenic mice with the cardiac-specific expression of TNF-α

verfasst von: Yoshihiro Higuchi, Takuro Niidome, Yuji Miyamoto, Yoshihiro Komohara, Tomotake Tokunou, Toru Kubota, Takahiko Horiuchi

Erschienen in: Heart and Vessels | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Gold nano-rods, rod-shaped gold nanoparticles, act as contrast agents for in vivo bioimaging, drug delivery vehicles and thermal converters for photothermal therapy. Pro-inflammatory cytokines play critical roles in the development of heart failure. We examined the delivery of GNRs into the failing heart of a transgenic (TG) mouse model of inflammatory cardiomyopathy with the cardiac-specific overexpression of TNF-α. We modified GNRs with polyethylene glycol (PEG) to avoid cytotoxicity and reduce the rapid clearance of nanoparticles from blood. PEG-modified GNRs (4.5 mM as gold atoms, 200 μL) were administered intravenously to TG (n = 7) and wild-type (WT) mice (n = 5). These were killed 24 h later, and the heart, lung, liver, kidney and spleen were excised. A quantitative analysis of gold was performed using inductively coupled plasma mass or optical emission spectrometry. The amount of gold (ng) in the TG heart (3.24 ± 1.56 ng/mg heart weight) was significantly greater than that in the WT heart (1.01 ± 0.19; p < 0.05). No significant differences were observed among the other organs of TG and WT mice. The amount of gold in the TG heart was significantly and positively correlated with the ratio of the ventricular weight to body weight, which is known to be an index of ventricular hypertrophy. In conclusion, PEG-modified GNRs accumulated in the inflammatory TG heart in proportion with the severity of ventricular hypertrophy.
Literatur
1.
Zurück zum Zitat Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C (2000) The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35:537–544CrossRefPubMed Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C (2000) The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35:537–544CrossRefPubMed
2.
Zurück zum Zitat Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988–998CrossRefPubMed Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988–998CrossRefPubMed
3.
Zurück zum Zitat Higuchi Y, McTiernan CF, Frye CB, McGowan BS, Chan TO, Feldman AM (2004) Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-α-induced cardiomyopathy. Circulation 109:1892–1897CrossRefPubMed Higuchi Y, McTiernan CF, Frye CB, McGowan BS, Chan TO, Feldman AM (2004) Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-α-induced cardiomyopathy. Circulation 109:1892–1897CrossRefPubMed
4.
Zurück zum Zitat Jang B, Park JY, Tung CH, Kim IH, Choi Y (2011) Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano 5:1086–1094CrossRefPubMed Jang B, Park JY, Tung CH, Kim IH, Choi Y (2011) Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano 5:1086–1094CrossRefPubMed
5.
Zurück zum Zitat Takahashi H, Niidome Y, Niidome T, Kaneko K, Kawasaki H, Yamada S (2006) Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. Langmuir 22:2–5CrossRefPubMed Takahashi H, Niidome Y, Niidome T, Kaneko K, Kawasaki H, Yamada S (2006) Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. Langmuir 22:2–5CrossRefPubMed
6.
Zurück zum Zitat Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y (2006) PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 114:343–347CrossRefPubMed Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y (2006) PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 114:343–347CrossRefPubMed
7.
Zurück zum Zitat Niidome T, Akiyama Y, Shimoda K, Kawano T, Mori T, Katayama Y, Niidome Y (2008) In vivo monitoring of intravenously injected gold nanorods using near-infrared light. Small 4:1001–1007CrossRefPubMed Niidome T, Akiyama Y, Shimoda K, Kawano T, Mori T, Katayama Y, Niidome Y (2008) In vivo monitoring of intravenously injected gold nanorods using near-infrared light. Small 4:1001–1007CrossRefPubMed
8.
Zurück zum Zitat Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, Pushpanketh S, McDonald JF, El-Sayed MA (2008) Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 269:57–66CrossRefPubMedPubMedCentral Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, Pushpanketh S, McDonald JF, El-Sayed MA (2008) Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 269:57–66CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat von Maltzahn G, Park JH, Agrawal A, Bandaru NK, Das SK, Sailor MJ, Bhatia SN (2009) Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 69:3892–3900CrossRefPubMedCentral von Maltzahn G, Park JH, Agrawal A, Bandaru NK, Das SK, Sailor MJ, Bhatia SN (2009) Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 69:3892–3900CrossRefPubMedCentral
10.
Zurück zum Zitat Niidome T, Akiyama Y, Yamagata M, Kawano T, Mori T, Niidome Y, Katayama Y (2009) Poly(ethylene glycol)-modified gold nanorods as a photothermal nanodevice for hyperthermia. J Biomater Sci Polym Ed 20:1203–1215CrossRefPubMed Niidome T, Akiyama Y, Yamagata M, Kawano T, Mori T, Niidome Y, Katayama Y (2009) Poly(ethylene glycol)-modified gold nanorods as a photothermal nanodevice for hyperthermia. J Biomater Sci Polym Ed 20:1203–1215CrossRefPubMed
11.
Zurück zum Zitat Akiyama Y, Mori T, Katayama Y, Niidome T (2009) The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release 139:81–84CrossRefPubMed Akiyama Y, Mori T, Katayama Y, Niidome T (2009) The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release 139:81–84CrossRefPubMed
12.
Zurück zum Zitat Haine AT, Niidome T (2017) Gold nanorods as nanodevices for bioimaging, photothermal therapeutics, and drug delivery. Chem Pharm Bull (Tokyo) 65:625–628CrossRef Haine AT, Niidome T (2017) Gold nanorods as nanodevices for bioimaging, photothermal therapeutics, and drug delivery. Chem Pharm Bull (Tokyo) 65:625–628CrossRef
13.
Zurück zum Zitat Shao X, Zhang H, Rajian JR, Chamberland DL, Sherman PS, Quesada CA, Koch AE, Kotov NA, Wang X (2011) 125I-labeled gold nanorods for targeted imaging of inflammation. ACS Nano 5:8967–8973CrossRefPubMedPubMedCentral Shao X, Zhang H, Rajian JR, Chamberland DL, Sherman PS, Quesada CA, Koch AE, Kotov NA, Wang X (2011) 125I-labeled gold nanorods for targeted imaging of inflammation. ACS Nano 5:8967–8973CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM (1997) Cardiac-specific overexpression of tumor necrosis factor-α causes lethal myocarditis in transgenic mice. J Cardiac Fail 3:117–124CrossRef Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM (1997) Cardiac-specific overexpression of tumor necrosis factor-α causes lethal myocarditis in transgenic mice. J Cardiac Fail 3:117–124CrossRef
15.
Zurück zum Zitat Higuchi Y, Chan TO, Brown MA, Zhang J, DeGeorge BR Jr, Funakoshi H, Gibson G, McTiernan CF, Kubota T, Jones WK, Feldman AM (2006) Cardioprotection afforded by NF-κB ablation is associated with activation of Akt in mice overexpressing TNF-α. Am J Physiol Heart Circ Physiol 290:H590–H598CrossRefPubMed Higuchi Y, Chan TO, Brown MA, Zhang J, DeGeorge BR Jr, Funakoshi H, Gibson G, McTiernan CF, Kubota T, Jones WK, Feldman AM (2006) Cardioprotection afforded by NF-κB ablation is associated with activation of Akt in mice overexpressing TNF-α. Am J Physiol Heart Circ Physiol 290:H590–H598CrossRefPubMed
16.
Zurück zum Zitat Kadokami T, McTiernan CF, Kubota T, Frye CS, Feldman AM (2000) Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest 106:589–597CrossRefPubMedPubMedCentral Kadokami T, McTiernan CF, Kubota T, Frye CS, Feldman AM (2000) Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest 106:589–597CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res 81:627–635CrossRefPubMed Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res 81:627–635CrossRefPubMed
18.
Zurück zum Zitat Komohara Y, Terasaki Y, Kaikita K, Suzuki H, Kodama T, Takeya M (2005) Clearance of apoptotic cells is not impaired in mouse embryos deficient in class A scavenger receptor types I and II (CD204). Dev Dyn 232:67–74CrossRefPubMed Komohara Y, Terasaki Y, Kaikita K, Suzuki H, Kodama T, Takeya M (2005) Clearance of apoptotic cells is not impaired in mouse embryos deficient in class A scavenger receptor types I and II (CD204). Dev Dyn 232:67–74CrossRefPubMed
19.
Zurück zum Zitat Takahashi H, Niidome Y, Yamada S (2005) Controlled release of plasmid DNA from gold nanorods induced by pulsed near-infrared light. Chem Commun (Camb) 17:2247–2249CrossRef Takahashi H, Niidome Y, Yamada S (2005) Controlled release of plasmid DNA from gold nanorods induced by pulsed near-infrared light. Chem Commun (Camb) 17:2247–2249CrossRef
20.
Zurück zum Zitat Okuda K, Fu HY, Matsuzaki T, Araki R, Tsuchida S, Thanikachalam PV, Fukuta T, Asai T, Yamato M, Sanada S, Asanuma H, Asano Y, Asakura M, Hanawa H, Hao H, Oku N, Takashima S, Kitakaze M, Sakata Y, Minamino T (2016) Targeted therapy for acute autoimmune myocarditis with nano-sized liposomal FK506 in rats. PLoS One 11:e0160944CrossRefPubMedPubMedCentral Okuda K, Fu HY, Matsuzaki T, Araki R, Tsuchida S, Thanikachalam PV, Fukuta T, Asai T, Yamato M, Sanada S, Asanuma H, Asano Y, Asakura M, Hanawa H, Hao H, Oku N, Takashima S, Kitakaze M, Sakata Y, Minamino T (2016) Targeted therapy for acute autoimmune myocarditis with nano-sized liposomal FK506 in rats. PLoS One 11:e0160944CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Ruiz-Esparza GU, Segura-Ibarra V, Cordero-Reyes AM, Youker KA, Serda RE, Cruz-Solbes AS, Amione-Guerra J, Yokoi K, Kirui DK, Cara FE, Paez-Mayorga J, Flores-Arredondo JH, Guerrero-Beltran CE, Garcia-Rivas G, Ferrari M, Blanco E, Torre-Amione G (2016) A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics. Eur J Heart Fail 18:169–178CrossRefPubMed Ruiz-Esparza GU, Segura-Ibarra V, Cordero-Reyes AM, Youker KA, Serda RE, Cruz-Solbes AS, Amione-Guerra J, Yokoi K, Kirui DK, Cara FE, Paez-Mayorga J, Flores-Arredondo JH, Guerrero-Beltran CE, Garcia-Rivas G, Ferrari M, Blanco E, Torre-Amione G (2016) A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics. Eur J Heart Fail 18:169–178CrossRefPubMed
22.
Zurück zum Zitat Fischer D, Rossa S, Landmesser U, Spiekermann S, Engberding N, Hornig B, Drexler H (2005) Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26:65–69CrossRefPubMed Fischer D, Rossa S, Landmesser U, Spiekermann S, Engberding N, Hornig B, Drexler H (2005) Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26:65–69CrossRefPubMed
23.
Zurück zum Zitat Akiyama Y, Mori T, Katayama Y, Niidome T (2012) Conversion of rod-shaped gold nanoparticles to spherical forms and their effect on biodistribution in tumor-bearing mice. Nanoscale Res Lett 7:565CrossRefPubMedPubMedCentral Akiyama Y, Mori T, Katayama Y, Niidome T (2012) Conversion of rod-shaped gold nanoparticles to spherical forms and their effect on biodistribution in tumor-bearing mice. Nanoscale Res Lett 7:565CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Higuchi Y, Kubota T, Koyanagi M, Maeda T, Feldman AM, Makino N (2012) Upregulation of anticoagulant proteins, protein S and tissue factor pathway inhibitor, in the mouse myocardium with cardio-specific TNF-α overexpression. Am J Physiol Heart Circ Physiol 302:H2352–H2362CrossRefPubMed Higuchi Y, Kubota T, Koyanagi M, Maeda T, Feldman AM, Makino N (2012) Upregulation of anticoagulant proteins, protein S and tissue factor pathway inhibitor, in the mouse myocardium with cardio-specific TNF-α overexpression. Am J Physiol Heart Circ Physiol 302:H2352–H2362CrossRefPubMed
Metadaten
Titel
Accumulation of gold nano-rods in the failing heart of transgenic mice with the cardiac-specific expression of TNF-α
verfasst von
Yoshihiro Higuchi
Takuro Niidome
Yuji Miyamoto
Yoshihiro Komohara
Tomotake Tokunou
Toru Kubota
Takahiko Horiuchi
Publikationsdatum
29.08.2018
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 3/2019
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-018-1241-2

Weitere Artikel der Ausgabe 3/2019

Heart and Vessels 3/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.